Grace Therapeutics
GRCE
#9797
Rank
$27.98 M
Marketcap
$2.04
Share price
-5.56%
Change (1 day)
-39.10%
Change (1 year)

Revenue for Grace Therapeutics (GRCE)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Grace Therapeutics from 2010 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A-100%
2021 $0.11 M41.98%
2020 $0.08 M
2019 N/A
2018 N/A
2016 $0.01 M-90.72%
2015 $0.11 M-47.52%
2014 $0.22 M-24.22%
2013 $0.29 M-57.32%
2012 $0.69 M498.81%
2011 $0.11 M
2010 N/A